227 related articles for article (PubMed ID: 25631128)
1. Melanoma stem cells.
Roesch A
J Dtsch Dermatol Ges; 2015 Feb; 13(2):118-24. PubMed ID: 25631128
[TBL] [Abstract][Full Text] [Related]
2. Spheres of influence in cancer stem cell biology.
Perego M; Alison MR; Mariani L; Rivoltini L; Castelli C
J Invest Dermatol; 2011 Feb; 131(2):546-7. PubMed ID: 20962857
[No Abstract] [Full Text] [Related]
3. Cancer stem cells and human malignant melanoma.
Schatton T; Frank MH
Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
5. Successes and limitations of targeted cancer therapy in melanoma.
Romano E; Michielin O
Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Melanoma Cell States and Plasticity with Zebrafish Models.
Travnickova J; Patton EE
J Invest Dermatol; 2021 Jun; 141(6):1389-1394. PubMed ID: 33340501
[TBL] [Abstract][Full Text] [Related]
7. Melanoma: do we need a hatchet or a scalpel?
Shackleton MJ; Quintana E; Fullen DR; Sabel MS; Johnson TM
Arch Dermatol; 2009 Mar; 145(3):307-8. PubMed ID: 19289763
[No Abstract] [Full Text] [Related]
8. Ultraviolet light and melanoma.
Craig S; Earnshaw CH; Virós A
J Pathol; 2018 Apr; 244(5):578-585. PubMed ID: 29380860
[TBL] [Abstract][Full Text] [Related]
9. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
10. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
[TBL] [Abstract][Full Text] [Related]
11. Melanoma stem cells--are there devils in the detail?
Shackleton M
Pigment Cell Melanoma Res; 2010 Oct; 23(5):693-4. PubMed ID: 20704685
[No Abstract] [Full Text] [Related]
12. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma.
Roesch A; Paschen A; Landsberg J; Helfrich I; Becker JC; Schadendorf D
Eur J Cancer; 2016 May; 59():109-112. PubMed ID: 27023049
[TBL] [Abstract][Full Text] [Related]
13. TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states.
Bordelon JR; Grichnik JM
Dermatol Ther; 2015; 28(3):177-8. PubMed ID: 25649199
[No Abstract] [Full Text] [Related]
14. Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?
Menaa F; Houben R; Eyrich M; Broecker EB; Becker JC; Wischhusen J
G Ital Dermatol Venereol; 2009 Jun; 144(3):287-96. PubMed ID: 19088701
[TBL] [Abstract][Full Text] [Related]
15. Targeting metastatic melanoma.
Flaherty KT
Annu Rev Med; 2012; 63():171-83. PubMed ID: 22034865
[TBL] [Abstract][Full Text] [Related]
16. Neural crest stem cells in melanoma development.
Shakhova O
Curr Opin Oncol; 2014 Mar; 26(2):215-21. PubMed ID: 24441506
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in understanding the pathology of malignant melanoma.
Kuphal S; Bosserhoff A
J Pathol; 2009 Dec; 219(4):400-9. PubMed ID: 19771562
[TBL] [Abstract][Full Text] [Related]
18. Melanoma biology and new targeted therapy.
Gray-Schopfer V; Wellbrock C; Marais R
Nature; 2007 Feb; 445(7130):851-7. PubMed ID: 17314971
[TBL] [Abstract][Full Text] [Related]
19. Melanoma resistance gene identified.
Bond T
Biomark Med; 2013 Apr; 7(2):199. PubMed ID: 23667941
[No Abstract] [Full Text] [Related]
20. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA.
Bell RE; Levy C
Pigment Cell Melanoma Res; 2011 Dec; 24(6):1088-106. PubMed ID: 22004179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]